Working Papers 21-30
Working paper 21
Brian Salter, Human ESC science, bioethics and the EU's Framework Programmes. July 2007
[This is a revised and update version of Working Paper 1]
Working Paper 23
Olivia Harvey,STS perspectives on the components of innovation in human embryonic stem cell research: A US case-study. July 2007
Working Paper 24
Brian Salter and Catherine Waldby,Contested governance in human embryonic stem cell science: uncertainty and standardisation in research and patenting. November 2007
Working Paper 25
Brian Salter, Bioethical governance and basic stem cell science: China and the global biomedicine economy. January 2008
Working Paper 26
Brian Salter and Olivia Harvey, Stem cell innovation in the United States: the benefits of the minimal state. April 2008
Working Paper 27
Catherine Waldby, Singapore Biopolis: Bare Life in the City State, April 2008.
Working Paper 28
Brian Salter,China, globalisation and health biotechnology innovation: venture capital and the adaptive state, February 2009
Working Paper 29
Brian Salter,Patents and morality: governing human embryonic stem cell science in Europe, October 2009
Working Paper 30
Brian Salter, Biomedical innovation and the geopolitics of patenting: China and the struggle for future territory, March 2010